ConductScience.org, home

Paper445964

Kinetics of intravenous melphalan.

Alberts DS and 7 others. Clin Pharmacol Ther, 1979. Cited by 111 papers, by iCite.

Cite this record

ConductScience Library. Kinetics of intravenous melphalan. Papers, record 445964. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/445964

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Kinetics of intravenous melphalan.
PubMed
Journal
Clin Pharmacol Ther
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
111
iCite
Relative citation ratio, by iCite
5.28
iCite
Revised in PubMed
2019-05-09
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alberts DSD S
2Chang SYS Y
3Chen HSH S
4Moon TET E
5Evans TLT L
6Furner RLR L
7Himmelstein KK
8Gross JFJ F

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MelphalanMajor topic
Adult
Aged
Blood Proteins
Female
Half-Life
Humans
Hydroxylation
In Vitro Techniques
Injections, Intravenous
Kinetics
Male
Metabolic Clearance Rate
Middle Aged
Protein Binding

Source PubMed

Download CSV of topics

Cited by36

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 111 citations.

PMIDTitleJournalYearIn PapersSource
36581339Evaluating the Impacts of CYP3A4*1B and CYP3A5*3 Variations on Pharmacokinetic Behavior and Clinical Outcomes in Multiple Myeloma Patients With Autologous Stem Cell Transplant.Cancer Genomics Proteomics2023https://conductscience.org/library/papers/36581339PubMed
36537564Clinical Impact of Melphalan Pharmacokinetics on Transplantation Outcomes in Children Undergoing Hematopoietic Stem Cell Transplantation.Cell Transplant2022https://conductscience.org/library/papers/36537564PubMed
34859337Population Pharmacokinetics of Melphalan in a Large Cohort of Autologous and Allogeneic Hematopoietic Cell Transplantation Recipients: Towards Individualized Dosing Regimens.Clin Pharmacokinet2022https://conductscience.org/library/papers/34859337PubMed
32848191Melphalan pharmacokinetics and transplant related toxicity during autologous stem cell transplantation.Bone Marrow Transplant2021https://conductscience.org/library/papers/32848191PubMed
31428821Pharmacokinetics of thiotepa in high-dose regimens for autologous hematopoietic stem cell transplant in Japanese patients with pediatric tumors or adult lymphoma.Cancer Chemother Pharmacol2019https://conductscience.org/library/papers/31428821PubMed
30631618Sinusoidal Obstruction Syndrome (SOS) in Multiple Myeloma with Renal Failure.Case Rep Oncol Med2018https://conductscience.org/library/papers/30631618PubMed
30261554
Population pharmacokinetics of carboplatin, etoposide and melphalan in children: a re-evaluation of paediatric dosing formulas for carboplatin in patients with normal or mild impairment of renal function.
Br J Clin Pharmacol2019https://conductscience.org/library/papers/30261554PubMed
16430310Mass balance studies, with a focus on anticancer drugs.Clin Pharmacokinet2006https://conductscience.org/library/papers/16430310PubMed
15752378Melphalan pharmacokinetics in children with malignant disease: influence of body weight, renal function, carboplatin therapy and total body irradiation.Br J Clin Pharmacol2005https://conductscience.org/library/papers/15752378PubMed
15656694Interactions between antiretrovirals and antineoplastic drug therapy.Clin Pharmacokinet2005https://conductscience.org/library/papers/15656694PubMed
8462127Glutathione depletion increases the cytotoxicity of melphalan to PC-3, an androgen-insensitive prostate cancer cell line.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8462127PubMed
7679331Phase II trial and pharmacokinetic assessment of intravenous melphalan in patients with advanced prostate cancer.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/7679331PubMed
7318146Pharmacologic studies of anticancer drugs with the human tumor stem cell assay.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7318146PubMed
7296753Melphalan estimation by quantitative thin-layer chromatography. Observations on melphalan hydrolysis in vitro and pharmacokinetics in rabbits.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7296753PubMed
7139852Plasma melphalan and prednisolone concentrations during oral therapy for multiple myeloma.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/7139852PubMed
6861266Pharmacokinetics of melphalan in children following high-dose intravenous injection.Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6861266PubMed
6840181The pharmacokinetics of melphalan in patients with multiple myeloma: an intravenous/oral study using a conventional dose regimen.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6840181PubMed
6705135Comparison of the fed and fasting states on the absorption of melphalan in multiple myeloma.Cancer Chemother Pharmacol1984https://conductscience.org/library/papers/6705135PubMed
6678879Pharmacokinetics of high dose melphalan.Invest New Drugs1983https://conductscience.org/library/papers/6678879PubMed
4053266In vitro evaluation of anticancer drugs in relation to development of drug resistance in the human tumor clonogenic assay.Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/4053266PubMed

See all 36 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/445964

GET https://conductscience.org/api/papers/v1/445964/cited_by?page=2